Pharming Group N.V. (AMS:PHARM)
0.8840
+0.0090 (1.03%)
Jul 18, 2025, 5:37 PM CET
Pharming Group Revenue
Pharming Group had revenue of $79.09M USD in the quarter ending March 31, 2025, with 42.29% growth. This brings the company's revenue in the last twelve months to $320.71M, up 24.13% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.
Revenue (ttm)
$320.71M
Revenue Growth
+24.13%
P/S Ratio
2.04
Revenue / Employee
$793.83K
Employees
404
Market Cap
605.67M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 297.20M | 51.88M | 21.15% |
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPharming Group News
- 2 days ago - Pharming Group to report second quarter and first half 2025 financial results and provide ... - GuruFocus
- 2 days ago - Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31 - GlobeNewsWire
- 25 days ago - Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis - GlobeNewsWire
- 5 weeks ago - Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders - GlobeNewsWire
- 7 weeks ago - Pharming Group to participate in June investor conferences - GlobeNewsWire
- 2 months ago - Pharming Group N.V. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Pharming Group N.V. GAAP EPS of $0.02, revenue of $79.1M misses by $1.82M - Seeking Alpha